WASHINGTON (AP) -- Federal health advisers said anemia drugs sold by Amgen Inc. and Johnson & Johnson should only be used by a limited segment of chemotherapy patients - a restriction that could cost the companies millions....
FDA Panel Wants Limits on Anemia DrugsCourtesy Headlines from the Associated Press Thu, 03/13/2008 - 16:27
WASHINGTON (AP) -- Federal health advisers said anemia drugs sold by Amgen Inc. and Johnson & Johnson should only be used by a limited segment of chemotherapy patients - a restriction that could cost the companies millions.... More related itemsFDA panel backs anemia drugs for kidney disease
FDA panel split on withdrawing diet pill Meridia
FDA panel mixed on approving Cymbalta for pain
The Unwritten Rules of Friendship: Simple Strategies...
|
Popular by tags WeekMonth |
Post new comment